HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Genome-wide siRNA screens have identified host cell factors important for efficient HIV infection, among which are nuclear pore proteins such as RanBP2/Nup358 and the karyopherin Transportin-3/TNPO3. Analysis of the roles of these proteins in the HIV replication cycle suggested that correct trafficking through the pore may facilitate the subsequent integration step. Here we present data for coupling between these steps by demonstrating that depletion of Transportin-3 or RanBP2 altered the terminal step in early HIV replication, the selection of chromosomal sites for integration. We found that depletion of Transportin-3 and RanBP2 altered integration targeting for HIV. These knockdowns reduced HIV integration frequency in gene-dense regions and near gene-associated features, a pattern that differed from that reported for depletion of the HIV integrase binding cofactor Psip1/Ledgf/p75. MLV integration was not affected by the Transportin-3 knockdown. Using siRNA knockdowns and integration targeting analysis, we also implicated several additional nuclear proteins in proper target site selection. To map viral determinants of integration targeting, we analyzed a chimeric HIV derivative containing MLV gag, and found that the gag replacement phenocopied the Transportin-3 and RanBP2 knockdowns. Thus, our data support a model in which Gag-dependent engagement of the proper transport and nuclear pore machinery mediate trafficking of HIV complexes to sites of integration.
Vyšlo v časopise:
HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2. PLoS Pathog 7(3): e32767. doi:10.1371/journal.ppat.1001313
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001313
Souhrn
Genome-wide siRNA screens have identified host cell factors important for efficient HIV infection, among which are nuclear pore proteins such as RanBP2/Nup358 and the karyopherin Transportin-3/TNPO3. Analysis of the roles of these proteins in the HIV replication cycle suggested that correct trafficking through the pore may facilitate the subsequent integration step. Here we present data for coupling between these steps by demonstrating that depletion of Transportin-3 or RanBP2 altered the terminal step in early HIV replication, the selection of chromosomal sites for integration. We found that depletion of Transportin-3 and RanBP2 altered integration targeting for HIV. These knockdowns reduced HIV integration frequency in gene-dense regions and near gene-associated features, a pattern that differed from that reported for depletion of the HIV integrase binding cofactor Psip1/Ledgf/p75. MLV integration was not affected by the Transportin-3 knockdown. Using siRNA knockdowns and integration targeting analysis, we also implicated several additional nuclear proteins in proper target site selection. To map viral determinants of integration targeting, we analyzed a chimeric HIV derivative containing MLV gag, and found that the gag replacement phenocopied the Transportin-3 and RanBP2 knockdowns. Thus, our data support a model in which Gag-dependent engagement of the proper transport and nuclear pore machinery mediate trafficking of HIV complexes to sites of integration.
Zdroje
1. RoeT
ReynoldsTC
YuG
BrownPO
1993 Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12 2099 2108
2. LewisPF
EmermanM
1994 Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68 510 516
3. BukrinskyMI
SharovaN
DempseyMP
StanwickTL
BukrinskayaAG
1992 Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A 89 6580 6584
4. von SchwedlerU
KornbluthRS
TronoD
1994 The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc Natl Acad Sci U S A 91 6992 6996
5. HeinzingerNK
BukrinskyMI
HaggertySA
RaglandAM
Kewalramani VK
1994 The vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A 91 7311 7315
6. BrassAL
DykxhoornDM
BenitaY
YanN
EngelmanA
2008 Identification of host proteins required for HIV infection through a functional genomic screen. Science 319 921 926
7. KonigR
ZhouY
EllederD
DiamondTL
BonamyGM
2008 Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135 49 60
8. ZhouH
XuM
HuangQ
GatesAT
ZhangXD
2008 Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4 495 504
9. ChristF
ThysW
De RijckJ
GijsbersR
AlbaneseA
2008 Transportin-SR2 imports HIV into the nucleus. Curr Biol 18 1192 1202
10. SuzukiY
CraigieR
2007 The road to chromatin - nuclear entry of retroviruses. Nat Rev Microbiol 5 187 196
11. EbinaH
AokiJ
HattaS
YoshidaT
KoyanagiY
2004 Role of Nup98 in nuclear entry of human immunodeficiency virus type 1 cDNA. Microbes Infect 6 715 724
12. KatzRA
GregerJG
BoimelP
SkalkaAM
2003 Human immunodeficiency virus type 1 DNA nuclear import and integration are mitosis independent in cycling cells. J Virol 77 13412 13417
13. SchroderAR
ShinnP
ChenH
BerryC
EckerJR
2002 HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110 521 529
14. MitchellRS
BeitzelBF
SchroderAR
ShinnP
ChenH
2004 Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2 E234
15. WuX
LiY
CriseB
BurgessSM
2003 Transcription start regions in the human genome are favored targets for MLV integration. Science 300 1749 1751
16. CarteauS
HoffmannC
BushmanFD
1998 Chromosome structure and HIV-1 cDNA integration: Centromeric alphoid repeats are a disfavored target. J. Virol 72 4005 4014
17. HolmanAG
CoffinJM
2005 Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc Natl Acad Sci U S A 102 6103 6107
18. BerryC
HannenhalliS
LeipzigJ
BushmanFD
2006 Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2 e157
19. VerdinE
1991 DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J Virol 65 6790 6799
20. LewinskiM
BisgroveD
ShinnP
ChenH
VerdinE
2005 Genome-wide analysis of chromosomal features repressing HIV transcription. J Virol 79 6610 6619
21. WeinbergerLS
BurnettJC
ToettcherJE
ArkinAP
SchafferDV
2005 Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 tat fluctuations drive phenotypic diversity. Cell 122 169 182
22. CherepanovP
MaertensG
ProostP
DevreeseB
Van BeeumenJ
2003 HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 278 372 381
23. EmilianiS
MousnierA
BusschotsK
MarounM
Van MaeleB
2005 Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J Biol Chem 280 25517 25523
24. MaertensG
CherepanovP
PluymersW
BusschotsK
De ClercqE
2003 LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 278 33528 33539
25. LlanoM
VanegasM
FregosoO
SaenzD
ChungS
2004 LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol 78 9524 9537
26. ShunMC
RaghavendraNK
VandegraaffN
DaigleJE
HughesS
2007 LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev 21 1767 1778
27. MarshallH
RonenK
BerryC
LlanoM
SutherlandH
2007 Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS One 2 e1340
28. CiuffiA
LlanoM
PoeschlaE
HoffmannC
LeipzigJ
2005 A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11 1287 1289
29. SilversRM
SmithJA
SchowalterM
LitwinS
LiangZ
2010 Modification of integration site preferences of an HIV-1-based vector by expression of a novel synthetic protein. Hum Gene Ther 21 337 349
30. GijsbersR
RonenK
VetsS
MalaniN
De RijckJ
2010 LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol Ther 18 552 560
31. FerrisAL
WuX
HughesCM
StewartC
SmithSJ
2010 Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration. Proc Natl Acad Sci U S A 107 3135 3140
32. LaiMC
LinRI
HuangSY
TsaiCW
TarnWY
2000 A human importin-beta family protein, transportin-SR2, interacts with the phosphorylated RS domain of SR proteins. J Biol Chem 275 7950 7957
33. WuJ
MatunisMJ
KraemerD
BlobelG
CoutavasE
1995 Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. J Biol Chem 270 14209 14213
34. LeeK
AmbroseZ
MartinTD
OztopI
MulkyA
2010 Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 7 221 233
35. YamashitaM
PerezO
HopeTJ
EmermanM
2007 Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog 3 1502 1510
36. WangGP
CiuffiA
LeipzigJ
BerryCC
BushmanFD
2007 HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 17 1186 1194
37. LanderE
2001 Initial sequencing and analysis of the human genome. Nature 409 860 921
38. VenterJC
2001 The sequence of the human genome. Science 291 1304 1351
39. KrishnanL
MatreyekKA
OztopI
LeeK
TipperCH
2010 The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol 84 397 406
40. LewinskiMK
YamashitaM
EmermanM
CiuffiA
MarshallH
2006 Retroviral DNA integration: Viral and cellular determinants of target-site selection. PLoS Pathog 2 e60
41. YamashitaM
EmermanM
2004 Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J Virol 78 5670 5678
42. XingY
JohnsonCV
MoenPT
Jr
McNeilJA
LawrenceJ
1995 Nonrandom gene organization: Structural arrangements of specific pre-mRNA transcription and splicing with SC-35 domains. J Cell Biol 131 1635 1647
43. SimonisM
KlousP
SplinterE
MoshkinY
WillemsenR
2006 Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat Genet 38 1348 1354
44. OsborneCS
ChakalovaL
BrownKE
CarterD
HortonA
2004 Active genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet 36 1065 1071
45. CasolariJM
BrownCR
KomiliS
WestJ
HieronymusH
2004 Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization. Cell 117 427 439
46. BricknerJH
WalterP
2004 Gene recruitment of the activated INO1 locus to the nuclear membrane. PLoS Biol 2 e342
47. CabalGG
GenovesioA
Rodriguez-NavarroS
ZimmerC
GadalO
2006 SAGA interacting factors confine sub-diffusion of transcribed genes to the nuclear envelope. Nature 441 770 773
48. TaddeiA
Van HouweG
HedigerF
KalckV
CubizollesF
2006 Nuclear pore association confers optimal expression levels for an inducible yeast gene. Nature 441 774 778
49. KurshakovaMM
KrasnovAN
KopytovaDV
ShidlovskiiYV
NikolenkoJV
2007 SAGA and a novel drosophila export complex anchor efficient transcription and mRNA export to NPC. EMBO J 26 4956 4965
50. MendjanS
TaipaleM
KindJ
HolzH
GebhardtP
2006 Nuclear pore components are involved in the transcriptional regulation of dosage compensation in drosophila. Mol Cell 21 811 823
51. BarrSD
CiuffiA
LeipzigJ
ShinnP
EckerJR
2006 HIV integration site selection: Targeting in macrophages and the effects of different routes of viral entry. Mol Ther 14 218 225
52. FollenziA
AilesLE
BakovicS
GueunaM
NaldiniL
2000 Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genetics 25 217 222
53. NaldiniL
BlomerU
GallayP
OryD
MulliganR
1996 In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 263 267
54. WangGP
GarrigueA
CiuffiA
RonenK
LeipzigJ
2008 DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res 36 e49
55. BradyT
AgostoLM
MalaniN
BerryCC
O'DohertyU
2009 HIV integration site distributions in resting and activated CD4+ T cells infected in culture. AIDS 23 1461 1471
56. BradyT
LeeYN
RonenK
MalaniN
BerryCC
2009 Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev 23 633 642
57. PryciakPM
VarmusHE
1992 Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69 769 780
58. PryciakPM
SilA
VarmusHE
1992 Retroviral integration into minichromosomes in vitro. EMBO J 11 291 303
59. PrussD
BushmanFD
WolffeAP
1994 Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci U S A 91 5913 5917
60. PrussD
ReevesR
BushmanFD
WolffeAP
1994 The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J Biol Chem 269 25031 25041
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 3
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- A Toxin that Hijacks the Host Ubiquitin Proteolytic System
- Invasive Extravillous Trophoblasts Restrict Intracellular Growth and Spread of
- Blood Meal-Derived Heme Decreases ROS Levels in the Midgut of and Allows Proliferation of Intestinal Microbiota
- Metabolite Cross-Feeding Enhances Virulence in a Model Polymicrobial Infection